HOME >> BIOLOGY >> NEWS
Belgian researchers explore revolutionary approach to angiogenesis

Geneva, Switzerland: A revolutionary approach to angiogenesis[1] by a team of Belgian researchers could make cancer treatment more effective at killing tumours.

Dr. Olivier Feron and his team from the University of Louvain Medical School in Brussels have turned the whole concept of targeting tumour blood vessels on its head. Instead of the conventional approach of trying to starve tumour cells of the blood supply they need to grow, they are doing the opposite opening up the tumour blood supply to allow better access for cancer drugs and more effective radiotherapy.

The potential for exploiting tumour blood vessels has been made possible by their discovery in a study in mice that the arterioles (blood vessels less than 0.5mm in diameter) that feed tumours have the ability to contract in response to increases in pressure within their lumen (the space within the blood vessels). Equivalent sized blood vessels in healthy tissue can't do this.

"What this means is that we may have the potential to use drugs to selectively exploit these blood vessels against the tumour instead of, or before, killing them. Exploiting tumour blood vessels instead of destroying them by anti-angiogenic drugs constitutes a paradigm shift in approach to angiogenesis," Dr. Feron told a news briefing today (Thursday 30 September) at the EORTC-NCI-AACR[2] Symposium on Molecular Targets and Cancer Therapeutics.

The key to the ability of tumour arterioles to contract lies with endothelin-1 (ET-1) a peptide released in large amounts by many tumour cells, which stimulates their proliferation.

"The effect of ET-1 in tumours has been underestimated up to now," Dr. Feron said. "ET-1 has been known for years in cardiology as a very potent blood vessel constrictor. Here, we found that the myogenic tone (mechanical force) with which the tumour blood vessels contract and expand is exquisitely dependent on the endothelin pathway.

"What we did was to us
'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
41-227-612-211
European Organisation for Research and Treatment of Cancer
30-Sep-2004


Page: 1 2

Related biology news :

1. Award winning researchers reveal potential new role for Glivec
2. $7.5 Million grant to Yale researchers for role of viruses in cancer
3. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
4. Joslin researchers clarify mechanisms for beta-cell formation
5. Virginia Tech researchers to release findings on Smith River Project
6. Molecular motor myosin VI moves hand over hand, researchers say
7. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
8. Emory researchers map structure of anti-cancer molecule
9. Leukemia stem cells identified by Stanford researchers
10. EURYI Award given for the first time to 25 young European researchers
11. Carnegie Mellon researchers to demonstrate autonomous robotthat will seek life in Atacama Desert

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/2/2018)... ... October 02, 2018 , ... ... to 27th, 2018 at Tampa Convention Center. The Palo Alto-based face recognition company, ... session on September 27th. Other speakers included U.S. Federal executives from Department of ...
(Date:10/1/2018)... (PRWEB) , ... October 01, 2018 , ... ... MDLIVE and 1200+ customers and InteloMed, the leading patient monitoring technology providing real-time ... vital signs and other indications of patient health during a telehealth visit without ...
(Date:9/28/2018)... ... 28, 2018 , ... Purification , The fluorescent-dye labeled bacmid DNA must be ... Kit. Samples were gently mixed with 275 µL of provided PB buffer (Qiagen), applied ... room temperature. Flow-through was discarded and 750 µL of provided PE buffer (Qiagen) was ...
Breaking Biology News(10 mins):
(Date:9/22/2018)... ... September 20, 2018 , ... Catalent Pharma Solutions, the leading ... consumer health products, today announced that it will be co-hosting a workshop with ... Development,”. The one-day event is to be held at the Hilton Boston Back ...
(Date:9/15/2018)... ... September 14, 2018 , ... Next-generation genomic sequencing is transforming what is ... challenges remain. In the past, the sheer size of genomics data has made sharing ... new data ecosystem developed to advance cures by reducing the technological barriers to data ...
(Date:9/13/2018)... ... September 13, 2018 , ... Asymmetrex’s director, James L. Sherley, M.D., ... in medicine, if we didn’t have the means to measure the number of drug ... answer, “Nowhere! And that is what’s holding up progress in stem cell medicine.” , ...
(Date:9/12/2018)... ... September 11, 2018 , ... Leading regenerative veterinary medicine ... Practitioners Conference (AAFP) later this month. The company’s CEO and founder, ... the treatment of chronic kidney disease in felines at a poster session on ...
Breaking Biology Technology:
Cached News: